Filed: 5/15/2025ACC: 0001892688-25-000116
📋 What this filing means
DIADEMA PARTNERS LP filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $383.27M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$383.27M
Total AUM (reported)
17.19M
Total Shares
Allocation by class
COM$314.10M82.0%
SHS USD$19.63M5.1%
ADR$17.88M4.7%
SPONSORED ADR$8.48M2.2%
COM NEW$6.59M1.7%
NAMEN AKT$3.81M1.0%
CL A$3.69M1.0%
Portfolio Concentration
Top 3$127.54M33.3%
4–10$131.28M34.3%
11–25$71.65M18.7%
Rest$52.81M13.8%
Top 3 weight
33.3%
Top 10 weight
67.5%
Voting Authority Distribution
Total shares with voting rights: 17.19M
Sole
Full voting authority
17.19M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
AMGEN INC
SOLEShares155.40K
TypeSH
Market value$48.41M
12.63%
Sole
155.40K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares50K
TypeSH
Market value$41.30M
10.77%
Sole
50K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares529.40K
TypeSH
Market value$37.83M
9.87%
Sole
529.40K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares49.83K
TypeSH
Market value$31.60M
8.25%
Sole
49.83K
Shared
0.00
None
0.00
PFIZER INC
SOLEShares900K
TypeSH
Market value$22.81M
5.95%
Sole
900K
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares190.20K
TypeSH
Market value$21.72M
5.67%
Sole
190.20K
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares158.09K
TypeSH
Market value$19.63M
5.12%
Sole
158.09K
Shared
0.00
None
0.00
NOVO-NORDISK A S
SOLEShares257.92K
TypeSH
Market value$17.88M
4.66%
Sole
257.92K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares33.12K
TypeSH
Market value$8.94M
2.33%
Sole
33.12K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares240.30K
TypeSH
Market value$8.70M
2.27%
Sole
240.30K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares207.88K
TypeSH
Market value$8.20M
2.14%
Sole
207.88K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares12.28K
TypeSH
Market value$7.18M
1.87%
Sole
12.28K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares62.25K
TypeSH
Market value$6.88M
1.80%
Sole
62.25K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares166.30K
TypeSH
Market value$6.21M
1.62%
Sole
166.30K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares143.99K
TypeSH
Market value$5.44M
1.42%
Sole
143.99K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares131.40K
TypeSH
Market value$4.54M
1.19%
Sole
131.40K
Shared
0.00
None
0.00
MODERNA INC
SOLEShares152.10K
TypeSH
Market value$4.31M
1.13%
Sole
152.10K
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares214.10K
TypeSH
Market value$3.98M
1.04%
Sole
214.10K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares112K
TypeSH
Market value$3.81M
0.99%
Sole
112K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares52.88K
TypeSH
Market value$3.74M
0.98%
Sole
52.88K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares154.12K
TypeSH
Market value$3.72M
0.97%
Sole
154.12K
Shared
0.00
None
0.00
RECURSION PHARMACEUTICALS IN
SOLEShares698.40K
TypeSH
Market value$3.69M
0.96%
Sole
698.40K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares593.61K
TypeSH
Market value$3.56M
0.93%
Sole
593.61K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares119.70K
TypeSH
Market value$3.51M
0.92%
Sole
119.70K
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares96.98K
TypeSH
Market value$2.88M
0.75%
Sole
96.98K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMGEN INCSOLE | COM | 155.40K | SH | $48.41M 12.63% | 155.40K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 50K | SH | $41.30M 10.77% | 50K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 529.40K | SH | $37.83M 9.87% | 529.40K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 49.83K | SH | $31.60M 8.25% | 49.83K | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 900K | SH | $22.81M 5.95% | 900K | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 190.20K | SH | $21.72M 5.67% | 190.20K | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 158.09K | SH | $19.63M 5.12% | 158.09K | 0.00 | 0.00 |
NOVO-NORDISK A SSOLE | ADR | 257.92K | SH | $17.88M 4.66% | 257.92K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 33.12K | SH | $8.94M 2.33% | 33.12K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 240.30K | SH | $8.70M 2.27% | 240.30K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 207.88K | SH | $8.20M 2.14% | 207.88K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 12.28K | SH | $7.18M 1.87% | 12.28K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 62.25K | SH | $6.88M 1.80% | 62.25K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 166.30K | SH | $6.21M 1.62% | 166.30K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 143.99K | SH | $5.44M 1.42% | 143.99K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 131.40K | SH | $4.54M 1.19% | 131.40K | 0.00 | 0.00 |
MODERNA INCSOLE | COM | 152.10K | SH | $4.31M 1.13% | 152.10K | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 214.10K | SH | $3.98M 1.04% | 214.10K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 112K | SH | $3.81M 0.99% | 112K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 52.88K | SH | $3.74M 0.98% | 52.88K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 154.12K | SH | $3.72M 0.97% | 154.12K | 0.00 | 0.00 |
RECURSION PHARMACEUTICALS INSOLE | CL A | 698.40K | SH | $3.69M 0.96% | 698.40K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 593.61K | SH | $3.56M 0.93% | 593.61K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 119.70K | SH | $3.51M 0.92% | 119.70K | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 96.98K | SH | $2.88M 0.75% | 96.98K | 0.00 | 0.00 |
Page 1 of 3